Back to search
A phase I trial of the oral cyclin dependent kinase inhibitor CYC202 in patients with advanced malignancy
Data up to Jan 2025
Published2004
Citations13
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
Loading...